The protective effect of delta-aminolevulinic acid dehydratase 1-2 and 2-2 isozymes against blood lead with higher hematologic parameters. by Kim, Hee-Seon et al.
538 VOLUME 112 | NUMBER 5 | April 2004 • Environmental Health Perspectives
Research | Article
Some workers are exposed to high environ-
mental lead levels in modern society. The
control of lead exposure by legislation and
modern technology is undoubtedly responsi-
ble for the reduction in acute lead poisoning
over the past few decades in Korea (Lee
1992). Despite these declines, there is still
considerable concern regarding the toxico-
logic implications of lead exposure and the
subtle health effects at blood lead (PbB) levels
around 30 µg/dL in Korean lead workers
with a signiﬁcantly higher prevalence of iron
deﬁciency (Kim et al. 2003).
There is a considerable interindividual
variation in the toxicokinetics of lead
(Fleming et al. 1998; Goering and Fowler
1987; Schwartz et al. 1995; Smith et al. 1995;
Wetmur et al. 1991b). Lead inhibits three
enzymes—aminolevulinic acid dehydratase
(ALAD), coporphyrinogen oxidase, and fer-
rochelatase—in the heme-synthesis pathway,
with its effects on ALAD being most pro-
found (Onalaja and Claudio 2000). The
ALAD polymorphism codes for one of three
isozymes (termed ALAD 1-1, ALAD 1-2, and
ALAD 2-2) and has been reported to account
for significant variation in intravascular and
soft-tissue binding and in the long-term
deposition of lead (Kelada et al. 2001). The
ALAD 2 allele has been shown to modify the
toxicokinetics of lead by coding for a more
electronegative enzyme that may bind posi-
tively charged lead ions more tightly than
does the ALAD-1 protein (Wetmur 1994;
Wetmur et al. 1991a). PbB concentrations are
reportedly higher in subjects carrying the
ALAD-2 allele than in subjects with the
ALAD 1-1 isozyme (Fleming et al. 1998;
Wetmur 1994; Wetmur et al. 1991a, 1991b;
Ziemsen et al. 1986). However, several other
studies (Bergdahl et al. 1997; Hu et al. 2001;
Schwartz et al. 1995; Smith et al. 1995) have
reported no association between ALAD geno-
types and PbB levels. The results of the studies
of Smith et al. (1995) and Hu et al. (2001)
suggest that ALAD modiﬁes PbB and/or the
toxicokinetics of lead only in those with a
high body lead burden. Recent studies into
occupational lead exposures support the
hypothesis that the protective effect of the
variant allele is due to the binding of lead and
maintaining it in the intravascular space in a
less bioavailable form with lowered zinc proto-
porphyrin (ZPP) levels, a parameter of the
hematologic toxic consequences of lead
(Fleming et al. 1998; Schwartz et al. 1997,
2000; Sithisarankul et al. 1997). 
Hypotheses concerning lower ZPP levels
even in the presence of higher concentrations
of PbB and the ALAD 1-2 or 2-2 isotype ques-
tion whether ALAD mediates the levels of
hematologic parameters. The prevalence of the
ALAD-2 allele varies with race and ethnicity.
For example, it has been reported that only
9.9% of Koreans carry the allele (Lee et al.
2001), whereas approximately 20% of
Caucasians have the allele (Onalaja and
Claudio 2000; Wetmur et al. 1991b; Ziemsen
et al. 1986). With increased attention being
paid to nutrition as a secondary means of miti-
gating the effects of occupational and environ-
mental exposure to lead (Cheng et al. 1998;
Mahaffey 1990), improved iron nutrition has
been found to be important to the reduction
of the toxicity of PbB (Mahaffey 1995). One
of the most prevalent nutritional concerns
among Korean lead workers has been a higher
prevalence of iron deﬁciency compared with
the general population, although the preva-
lence of anemia in the overall Korean male
population is no longer of serious concern.The
recent study of Kim et al. (2003) showed that
42% of lead workers have low iron store status
compared with only 21% of control subjects.
For both populations, the prevalence of ane-
mia determined by a hemoglobin (Hb) level
< 13.5 g/dL was very low (13% lead workers
vs. 0% control), and the mean Hb level was
14.7 g/dL. This study also indicated that the
dietary iron intake was inversely associated
with ZPP. If the ALAD genotype modifies
hematologic parameters to reduce ZPP even
in the presence of higher PbB, nutritional
management strategies for secondary preven-
tive intervention against lead toxicity should
vary with ALAD genotype. Here we report a
cross-sectional evaluation of differences of
hematologic parameters by ALAD genotype in
1,219 male lead workers from Korea.
Materials and Methods
Study population. Participation in the study
was voluntary, and all participants provided
written, informed consent. The study pro-
tocol was approved by the Institutional
Review Board of the College of Medicine,
Soonchunhyang University.
Employees from eight lead-using factories
[ﬁve storage-battery factories, two secondary-
smelting factories, and one litharge (PbO)
making factory] were studied. Storage-battery
factories manufacture batteries for cars and
trucks, large industrial batteries, and/or
smaller batteries for consumer products. All of
the workers included in the study were male,
and they were either lead workers who were
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nonlead workers who were engaged in
administrative or clerical jobs at the same eight
factories. Both lead and nonlead workers were
screened at a mandatory semi-annual health
surveillance program that included environ-
mental and biologic monitoring (e.g., levels of
PbB, ZPP, and Hb) and liver and renal func-
tion examinations by the Institute of Industrial
Medicine, Soonchunhyang University. Workers
without any detectable medical problems were
considered eligible subjects for the present
study. Out of a total of 1,287 male workers,
the eligible study participants consisted of
1,074 lead workers (88%) and 145 nonlead
workers (12%), with a mean age of 35.8 years
(range, 19–72 years). The mean employment
duration of lead workers was 6.7 years (range,
0–27 years), and that of nonlead workers was
5.9 years (range, 0–20 years).
Study variables. ALAD genotype, PbB,
and Hb levels were determined in EDTA-
treated whole-blood specimens obtained dur-
ing medical surveillance in autumn 2000 at
Soonchunhyang University. A modiﬁed poly-
merase chain reaction (PCR)-based protocol
was used for ALAD genotyping (Wetmur et al.
1991a, 1991b), performed sequentially and in
duplicate on 0.5 µL whole blood using nested
primers. Detailed descriptions of the ALAD
genotyping methods are available elsewhere
(Lee et al. 2001). PbB was measured in dupli-
cate with a Zeeman background-corrected
atomic absorption spectrophotometer (model
Z-8100; Hitachi, Tokyo, Japan) using the
standard addition method of the National
Institute of Occupational Safety and Health
(Kneip and Crable 1988) at the Institute
of Industrial Medicine, Soonchunhyang
University, which is a certiﬁed reference labo-
ratory for lead measurement in Korea. ZPP
levels were measured by a portable hemato-
ﬂuorometer (Aviv-206; Aviv, Lakewood, NJ,
USA) at the medical surveillance sites
(Blumberg et al. 1977). Hb was assayed by
the cyanmethemoglobin method (model
Ac-T; Beckman Coulter, Fullerton, CA,
USA). Serum iron (SFe) levels were measured
by spectrophotometry (TBA-40FR biochemi-
cal analyzer; Hitachi, Tokyo, Japan).
Data analysis. The primary goals of the
analysis were to examine relations of the ALAD
genotypes with hematologic parameters (blood
ZPP and Hb), PbB, and SFe while controlling
for covariates, and to evaluate whether the
ALAD genotype modiﬁed relations with PbB
or SFe on above relations.
Statistical analyses were performed using
SAS, version 8.12 (SAS Institute, Cary, NC,
USA). Detailed frequency distributions and
summary statistics were examined for all study
variables. Relations between variables were
assessed by correlations and multiple linear
regressions for continuous outcome data, and
multiple logistic regression for dichotomous
outcomes. These analyses were conducted on
data from all workers in both direct lead-
using and nonlead-using environments in the
same factories because the PbB levels of non-
lead workers in the study were significantly
higher than the mean PbB level of the general
Korean population (0.24 µmol/L, 5 µg/dL)
(Kim et al. 2001).
Covariates examined in linear regression
and logistic regression models comprised age,
employment duration, body mass index
(BMI), and alcohol and tobacco consumption.
Covariates were retained in the final regres-
sion and logistic models if they were signifi-
cant predictors of hematologic parameters.
We transformed ZPP values to a logarithmic
scale to account for the skewness of the ZPP
distribution. Multiple linear regression was
used to examine the association between
ALAD and log ZPP or Hb concentration
after controlling for PbB, SFe, and other
covariates. To evaluate the effect of modiﬁca-
tion by ALAD, we added cross-product terms
of ALAD × PbB and ALAD × SFe to the
models of log ZPP and Hb (one cross-product
at a time).
Crude and adjusted odds ratios (ORs) were
calculated using logistic regression to identify
predictors of anemia (Hb levels < 13.5 g/dL)
from the ALAD genotype among all workers,
controlling covariates. Given that the ALAD
genotype appears to modify lead toxico-
kinetics and that SFe is a source of iron in the
biosynthesis pathway of Hb, we hypothesized
that both ALAD genotype and iron status are
selection factors for special nutrition care for
the prevention of anemia. To evaluate the
relations of SFe with ALAD and Hb, we cal-
culated crude and adjusted OR of the ALAD
genotypes, dichotomous iron status (normal
and deﬁcient), and anemic status (normal and
anemic) using logistic regression analysis. A
deﬁcient iron status was deﬁned as SFe levels
< 10.74 µmol/L (60 µg/dL), which is a recog-
nized cutoff value for iron-deficient erythro-
poiesis (Gibson 1990).
Results
Descriptive results. Lead workers exhibited a
higher mean PbB level and a higher mean
ZPP level than nonlead workers (Table 1).
The majority of both lead and nonlead work-
ers currently consumed both tobacco and
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Table 1. Characteristics of study subjects.
Variables Lead workers (n = 1,074) Nonlead workers (n = 145)
Age (years) 35.4 ± 8.1 (19.0–70.0) 36.1 ± 7.6 (20.0–72.0)
Employment duration (years) 6.7 ± 4.6 (0.0–27.0) 5.9 ± 4.5 (0.0–20.0)
BMI 22.7 ± 2.7 (16.5–34.4) 23.6 ± 2.7 (17.4–32.7)
PbB
µmol/L 1.25 ± 0.66 (0.19–4.06) 0.45 ± 0.14** (0.17–0.80)
µg/dL 26.0 ± 13.7 (4.0–84.6) 9.4 ± 3.0** (3.5–16.6)
ZPP
µmol/mol heme 71.1 ± 51.1 (32.2–620.2) 53.3 ± 10.0* (32.2–79.8)
µg/dL 50.8 ± 36.5 (23.0–443.0) 38.0 ± 7.1* (23.0–57.0)
Hb (g/dL) 14.7 ± 0.9 (10.1–17.7) 14.9 ± 0.9 (12.1–17.8)
SFe (µmol/L) 20.2 ± 7.7 (4.1–85.4) 20.0 ± 8.6 (6.8–64.1)
Smoking [n (%)]
Current  786 (73.2) 96 (66.2)
Never smoked or ex-smoker 288 (26.8) 49 (33.8)
Alcohol consumption [n (%)]
Current 824 (76.7) 114 (78.6)
Never or no longer 250 (23.2) 31 (21.4)
ALAD genotype [n (%)]
1-1 971 (90.4) 135 (93.1)
1-2 or 2-2 103 (9.6) 10 (6.9)
Values shown are mean ± SD (range). 
*p < 0.05; **p < 0.01.
Table 2. Lead biomarker variables and hematologic indices by ALAD gene status.
Variables ALAD 1-1 (n = 1,106) ALAD 1-2/2-2 (n = 113)
Age (years) 35.5 ± 8.0 (20.0–72.0) 35.6 ± 8.0 (19.0–63.0)
Employment duration (years) 6.6 ± 4.6 (0.0–27.0) 6.8 ± 4.6 (0.0–20.0)
BMI 22.9 ± 2.8 (16.7–34.4) 22.7 ± 2.4 (16.5–28.0)
PbB
µmol/L 1.15 ± 0.67 (0.17–4.66) 1.23 ± 0.66 (0.19–3.18)
µg/dL 23.9 ± 14.0 (3.5–84.6) 25.6 ± 13.7 (3.9–66.3)
ZPP
µmol/mol heme 69.9 ± 50.2 (32.2–620.2) 60.5 ± 23.3 (32.2–161.0)
µg/dL 49.9 ± 35.8 (23.0–443.0) 43.2 ± 16.6 (23.0–115.0)
Hb (g/dL) 14.7 ± 0.9 (10.1–17.8) 14.9 ± 0.8 (12.3–17.2)
SFe (µmol/L) 20.2 ± 7.9 (4.12–85.38) 20.6 ± 7.2 (9.0–41.5)
Values shown are mean ± SD (range). alcohol. Ninety percent of both types of work-
ers were homozygous for the ALAD 1-1 geno-
type (Table 1). Age, duration of job, BMI,
and Hb and SFe levels did not vary with
ALAD genotype (Table 2). There were also no
signiﬁcant differences in PbB and ZPP levels
by ALAD genotype.
Correlation of variables and associations
with ALAD genotype. Table 3 lists the unad-
justed correlations of study variables. As
expected, PbB concentrations were strongly
positively correlated with log ZPP (r = 0.689)
and negatively correlated with Hb (r = –0.195).
Log ZPP values were also negatively correlated
with Hb (r = –0.313) and showed a very weak
negative correlation with SFe (r = –0.059,
p < 0.05).
In multiple linear regression models,
ALAD genotype was associated with log ZPP
(Table 4, model 1). The results of Hb
(model 2) with ALAD genotype showed that
subjects with ALAD 1-2 or 2-2 isozymes had
signiﬁcantly (p < 0.05) higher Hb levels when
PbB and SFe levels and other confounding
covariates (age, employment duration, BMI,
alcohol consumption, and cigarette smoking)
were controlled. There were no significant
interactions of ALAD genotype with PbB or
SFe (data not shown). The hypothesis that
ALAD genotype modifies hematologic para-
meters was conﬁrmed: the mean Hb level was
0.22 g/dL higher in subjects with the ALAD-2
allele. Subjects with the ALAD 1-1 allele with
a higher amount of bioavailable lead showed
exacerbated hematologic toxicity with similar
PbB and SFe levels.
Predictors of anemia. The logistics regres-
sion model showed that the ALAD genotype
was associated with the presence of anemia
(Table 5). After dichotomizing anemic and
normal ranges of Hb at 13.5 g/dL (Gibson
1990), persons with ALAD 1-1 were more
likely to have anemia [crude OR = 3.4; 95%
confidence interval (95% CI), 1.2–13.5].
These associations were also observed after
controlling for age, employment duration,
BMI, alcohol consumption, and cigarette
smoking. The interaction of ALAD with SFe
was analyzed to examine whether the ALAD
genotype moderates the effect of iron status;
no interaction was observed (data not shown).
The analysis was further conducted with
grouped subjects by their iron-deficient ery-
thropoietic status as determined by SFe levels
< 10.74 µmol/L (60 µg/dL) (Gibson 1990).
As expected, individuals with iron-deficient
erythropoietic status were more likely to have
anemia, with an adjusted OR of 3.5 (95% CI,
1.7–7.0; data not shown). Moreover, when
subjects with the ALAD 1-1 genotype were
also iron deﬁcient (n = 65), their probability
of being anemic was 11.8-fold higher than
that of subjects with ALAD 1-2/2-2 genotypes
and normal iron status (95% CI, 2.3–58.6).
When subjects with normal iron status were
compared, individuals with the ALAD 1-1
genotype were 5.2-fold more likely to be ane-
mic than were individuals with the ALAD-2
allele (95% CI, 1.2–22.6). Comparison
among subjects with iron-deficient status by
ALAD genotypes was not possible because
only one subject had both the ALAD-2 allele
and anemia.
Discussion
The decline in PbB levels among Korean lead
workers over the past few decades reﬂects pri-
mary interventions including legislation on
adequate industrial hygiene practices,
improved work environments, and manda-
tory health surveillance. Nonetheless, consid-
erable concern remains regarding lead levels,
and proper nutrition has been recognized as
an adjunct to the reduction of occupational
lead exposure by altering susceptibility to lead
toxicity. In addition, studies using genetic
markers of susceptibility to environmental
toxicants have suggested that certain genes can
make individuals more vulnerable to environ-
mental toxins such as lead. The present study
focused on the relationship between different
ALAD genotypes and differentiated lead-
induced impairment of hematopoiesis, as an
aid to seeking appropriate nutritional strate-
gies to counteract the hematologic toxicity of
lead exposure.
Data from male Korean lead workers with
similar PbB and SFe concentrations, dura-
tions of employment in lead industry, BMIs,
and ages suggest that the ALAD genotype
inﬂuences levels of ZPP and Hb and, conse-
quently, the prevalence of anemia. Subjects
with the ALAD 1-2 or 2-2 genotype showed
significantly lower log ZPP and higher Hb
levels compared with ALAD 1-1 individuals
(Table 4). This analysis was conducted to
evaluate whether ALAD genotype modified
the relation between lead exposure and Hb
synthesis with differentiated ZPP levels
(log ZPP).
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Table 3. Correlation analysis of study variables.a
Employment
Age duration BMI PbB Log ZPP Hb
Employment duration 0.50***
BMI 0.10** 0.12***
PbB 0.35*** 0.18*** –0.05
Log ZPP 0.34*** 0.13*** –0.03 0.69***
Hb –0.22*** –0.03 0.22*** –0.20*** –0.31***
SFe 0.01 0.04 –0.01 –0.00 –0.06* 0.16***
aUnadjusted Pearson’s correlation for all subjects. *p < 0.05. **p < 0.01. ***p < 0.001.
Table 4. Multiple linear regression models of log ZPP (model 1) and Hb (model 2) with SFe, PbB, and ALAD
genotype.a
Estimate SE t-Statistic No. R2
Model 1: log ZPP with ALAD
Intercept 3.63 0.08 45.23*** 1,219 0.50
SFe (µmol/L) –0.003 0.001 –2.40*
PbB (µmol/L) 0.39 0.01 30.10***
ALAD 1-2/2-2 –0.11 0.03 –4.03*
Model 2: Hb with ALAD
Intercept 133.13 2.55 52.19*** 1,219 0.16
SFe (µmol/L) 0.19 0.03 5.78***
PbB (µmol/L) –1.67 0.41 –4.11***
ALAD 1-2/2-2 2.16 0.88 2.46*
aIn addition to variables listed under each model, models also controlled for age, employment duration, alcohol consumption,
and cigarette smoking for all subjects. *p < 0.05. ***p < 0.001.
Table 5. Association between dichotomous outcome variables of hemoglobin with ALAD genotype and
SFe status.a
ALAD Hb Crude OR Adjusted OR
genotype Iron statusb Normal Anemicc Total (95% CI) (95% CI)d
1-2/2-2 — 110 (97%) 3 (3%) 113 1.0 1.0
1-1 — 1,013 (91%) 93 (9%) 1,106 3.4 (1.2–13.5) 4.1 (1.0–13.7)
Total — 1,123 96 1,219
1-2/2-2 Normal 105 (98%) 2 (2%) 107 1.0 1.0
1-1 Normal 962 (92%) 79 (8%) 1,041 4.3 (1.3–26.4) 5.2 (1.2–22.6)
1-2/2-2 Deﬁcient 5 (83%) 1 (17%) 6 10.5 (0.4–130.1) 13.2 (0.5–348.0)
1-1 Deﬁcient 51 (78%) 14 (22%) 65 14.4 (3.8–93.9) 11.8 (2.3–58.6)
Total 1,123 96 1,219
aLogistic regression models for all subjects. bCutoff value for iron-deﬁciency: SFe level = 10.74 µmol/L (60 µg/dL). cCut-off
value for anemia: Hb level = 13.5 g/dL. dAdjusted for age, employment duration, BMI, alcohol consumption, and cigarette
smoking.Article | Protective effect of δ-ALAD genotype on blood lead
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ZPP levels, derived from the substrate
(protoporphyrin IX) of the last enzyme in the
heme-synthesis system (ferrochelatase),
should only be increased by the presence of
bioavailable lead; PbB that is strongly bound
by an ALAD isozyme, for example, should
not inhibit ferrochelatase. Therefore, lead
binding by ALAD isozymes with different
afﬁnities differentially limits its bioavailability
(Schwartz et al. 1995). We hypothesized that
the different bioavailability of PbB deter-
mined by ALAD isotypes differentially affects
ferrochelatase activity and therefore Hb syn-
thesis. Our data involving different Hb con-
centrations of different ALAD isotypes
conﬁrmed this hypothesis.
Furthermore, the prevalence of anemia in
subjects with ALAD 1-2/2-2 isotypes was sig-
niﬁcantly lower than in subjects homozygous
for ALAD 1-1 (Table 5). Anemia is a late sign
in industrial lead poisoning, and in the past it
was severe among subjects exposed to lead
(Mahaffey 1995). However, recent data indi-
cate that anemia is less intense and less com-
mon in Korean lead workers than previously
thought, although impaired iron status has
been reported in this population (Kim et al.
2003). Lead intoxication impairs iron use and
produces a hemolytic tendency, both of which
complicate the mechanism of anemia
(Albahary 1972). As mentioned above, the
two target sites in the biosynthetic pathway of
heme by PbB are the sites of activity of ALAD
and ferrochelatase (Moore and Goldberg
1985). Lead is also known to interfere with
the mitochondrial energy metabolism that is
necessary to reduce ferric iron to ferrous iron
before the insertion of iron into the porphyrin
ring. Therefore, protoporphyrin accumulates
when there is insufficient ferrous iron for its
incorporation by ferrochelatase into heme
(Mahaffey 1990). Ferrochelatase activity is
sensitive to both lead and iron. Kapoor et al.
(1984) reported that the enzyme kinetics of
ferrochelatase in isolated human reticulocytes
changes with both iron and lead concentra-
tions. Ferrochelatase is more sensitive to lead
effects when iron deficiency is present. Our
data provide evidence that the ALAD geno-
type modiﬁes both the toxicokinetics of lead
in the hematologic pathway and the preva-
lence of anemia in lead exposure. In addition,
our findings suggest that with impaired iron
status and the presence of the ALAD 1-1
genotype, reduction of heme synthesis causes
higher incidences of anemia when PbB levels
are controlled (Table 5). These data imply
that subjects with ALAD 1-2 or 2-2 are better
able to use iron for Hb synthesis. Therefore,
the impaired iron nutrition of individuals with
the ALAD 1-1 isozyme will make them more
susceptible to the toxic effects of lead in heme
biosynthesis than subjects with other ALAD
isozymes. Because the prevalence of anemia
can be modiﬁed by iron status, it is important
to reduce the more severe adverse effects of
lead on the hematologic system of subjects
with the ALAD 1-1 genotype, by improving
their iron nutritional status.
Many investigators have reported that
most Asians have the ALAD 1-1 genotype
(Lee et al. 2001; Onalaja and Claudio 2000;
Ziemsen et al. 1986). The Korean subjects
comprising the population of the present
study confirmed that tendency. The com-
bined risks of marginal iron nutritional status
found previously by Kim et al. (2003) and the
higher prevalence of ALAD 1-1 isotype
among Koreans together result in Korean lead
workers being at greater risk of lead toxicity in
the hematologic pathway. Therefore, careful
nutritional intervention as a secondary preven-
tion strategy for reducing the risk of lead toxi-
city needs to be developed while considering
the ALAD genotypes involved.
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